¿A qué nos dedicamos?

IsoSolutions Marketing & Management Inc. ofrece una amplia gama de productos de diferentes proveedores que incluye todos los instrumentos necesarios para equipar un laboratorio de medicina nuclear y también soporte técnico.

David

David T. Drummond Director General

Las personas son lo más importante. Cada organización debe tener como objetivo mejorar a las personas que trabajan para ella. En el sector de la salud usualmente el más importante es el paciente, pero también debe incluir a nuestros proveedores, clientes, empleados, socios — todos aquellos cuya vida es tocada por nuestra empresa.

85

Compañías conectadas
a través de isoSolutions

1493

Productos vendidos alrededor
del mundo en el 2016

98%

Encargos entregados
a tiempo en el 2016

Article

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

Kevin Yang ⎜ Feb 25, 2019

The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in paraganglioma (PGL) patients is lacking. The aim of this study was to evaluate the role of combined capecitabine and 177Lu-DOTATATE in malignant PGL patients.

seguir leyendo

Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)

David T. Drummond ⎜ Feb 21, 2019

Academic journals have published a large number of papers in the therapeutic nuclear medicine (NM) research field in the last 10 years. Despite this, a literature analysis has never before been made to point out the research interest in therapeutic radionuclides (RNs). For this reason, the present study aims specifically to analyze the research output on therapeutic radiometals from 2008 to 2018, with intent to quantify and identify global trends in scientific literature and emphasize the interdisciplinary nature of this research field.

seguir leyendo

Calendario

Apr 1 to 5

11th International Symposium on Targeted-Alpha-Therapy, 2019

11th International Symposium on Targeted-Alpha-Therapy, April 1-5, 2019 in Ottawa, Ontario, Canada. isoSolutions is pleased to inform you that we will attend the 11th International Symposium on Targeted-Alpha-Therapy (TAT11). You can find us at booth 28 the Exhibit Hall at the Fairmont Chateau Laurier.

Nov 13 to 16

ALASBIMN 2019 Annual Meeting

isoSolutions will be attending the ALASBIMN 2019 Annual Meeting to be held in Lima, Peru November 13 to 16, 2019. Marvin Calderon, Regional Sales and Marketing Manager Sales for Latin America hopes to see you there. If you would like to arrange a time and place to meet him, please contact mcalderon@isosolutions.com.

Feb 07 to 09

CANM 2019 Annual Meeting

isoSolutions will be attending the CANM 2019 Annual Meeting to be held in Québec, QC, Canada February 07 to 09, 2019. Pat Acton, Regional Sales and Marketing Manager Sales for Canada and US hopes to see you there. If you would like to arrange a time and place to meet her, please contact pacton@isosolutions.com.

[metaslider id="2027"]